Home | Welcome to Contract Pharma   
Last Updated Sunday, January 25 2015

Print

Search Results for 'Financial Report: Alkermes'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published October 31, 2014
Revenues up 14% in the quarter Read More »
Published April 30, 2014
Manufacturing and royalty revenues down 24% in the quarter Read More »
Published October 31, 2013
Revenues up 13%, loss narrows Read More »
Published July 25, 2013
Key commercial products up 22% in the quarter Read More »
Published January 31, 2013
Revenues up 8% in the quarter Read More »
Alkermes
By Fidelma Callanan, Sr. Director Marketing and Commercial Development
Four decades delivering contract pharma solutions for our Partners Alkermes Contract Pharma Services provid… Read More »
Published November 1, 2012
Revenues climb 72% Read More »
Published November 3, 2011
Elan portfolio makes contribution Read More »
By Michael Martorelli
Published November 6, 2009
Feel Better Now? Ending one year, approaching the next By Michael A. Martorelli It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »
By Gareth Davies, Sales&Marketing Director
Dales Pharmaceuticals provides a comprehensive range of pharmaceutical services including formulation development, analytical methods development, validation and stability testing plus contract manufacturing and packing. Dosage forms produced include… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On